Richard R. Heuser – författare

Peripheral vascular disease is a common, disabling malady, and patients seeking treatment may turn to their cardiologist for advice and treatment. Conventional treatment has always been medical management and, inevitably, surgical bypass, even amputation. Stents have had a significantly high impact on endoluminal treatment outcomes by preventing injury to the lumen, reducing the potential for hyperplasia and restenosis, as well as the likelihood of plaque disruption and embolization. This second edition brings together a combination of all the current evidence-based information with personal experience and is presented by a team of distinguished operators.Short Contents

Peripheral vascular disease is a common, disabling malady, and patients seeking treatment may turn to their cardiologist for advice and treatment. Conventional treatment has always been medical management and, inevitably, surgical bypass, even amputation. Stents have had a significantly high impact on endoluminal treatment outcomes by preventing injury to the lumen, reducing the potential for hyperplasia and restenosis, as well as the likelihood of plaque disruption and embolization. This second edition brings together a combination of all the current evidence-based information with personal experience and is presented by a team of distinguished operators.Short Contents

Hypertension remains the leading cause of cardiovascular morbidity and mortality in spite of current medical therapies. It has been estimated that 50% of Western civilization has hypertension and approximately 20% of patients have resistant hypertension. Renal denervation (RDN) is a minimally invasive, endovascular catheter based procedure using radiofrequency ablation aimed at treating resistant hypertension. Early studies show a high degree of effectiveness in renal denervation to treat hypertension.

This book examines renal pathophysiology and the rationale for renal denervation, as well as possible long term benefits and risks of this new therapy.  The myriad of devices involved in the evolution of this therapy are discussed and the book concludes with analyses of the cost effectiveness and future applications.

This extensively revised edition examines renal pathophysiology and the rationale for renal denervation for the management of hypertension, as well as possible long-term benefits and risks of this therapy. Renal denervation is a minimally invasive, endovascular catheter-based procedure that makes use of radiofrequency ablation to treat resistant hypertension, with studies showing a high degree of effectiveness. The devices involved in the continued evolution of this therapy are discussed and the book incorporates analyses of the development of the technique while evaluating its cost effectiveness and future applications.

Renal Denervation: Treatment and Device-Based Neuromodulation describes the technique in detail, its advances and its pitfalls. While it has been estimated that 50% of Western civilization has hypertension and approximately 20% of patients have resistant hypertension, hypertension remains the leading cause of cardiovascular morbidity and mortality thus strengthening arguments to consider a wider range of potential solutions to manage these patients.